Adaptimmune Therapeutics Eulerpool News

Adaptimmune Therapeutics Eulerpool News

Adaptimmune Therapeutics Stock News

Adaptimmune Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Adaptimmune Therapeutics news here.

• July 3 ·

  Yahoo
  3 Biotech Moonshots With Imminent Catalyst Potential
• July 3 ·

  Yahoo
  5 FDA decisions to watch in the third quarter
• July 3 ·

  SeekingAlpha
  Adaptimmune: How The Story Is Shaping Up For The Latter Half Of 2024
• July 2 ·

  Yahoo
  Fireside Chat with Adrian Rawcliffe, Chief Executive Officer of Adaptimmune
• June 12 ·

  Yahoo
  ADAP: Initiating Coverage of Adaptimmune, a Leading T-Cell Therapy Company
• June 11 ·

  TipRanks
  Adaptimmune Enhances Executive Severance and Benefit Terms
• June 4 ·

  TipRanks
  Adaptimmune Therapeutics (ADAP) Gets a Buy from TD Cowen
• June 4 ·

  TipRanks
  Buy Rating for Adaptimmune on Strong Partnership Potential and Financial Upside
• June 4 ·

  TipRanks
  Adaptimmune’s Strategic Collaboration with Galapagos: A Cautious Hold Amid Promising Developments
• June 3 ·

  Yahoo
  Adaptimmune to Present Data from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise